If you or a loved one were injured by an IVC Filter, get an attorney who has worked on such cases. ou have actually to suffer damages to file a lawsuit. Your lawyer will take your case and tell you what you can expect when filing your lawsuit. Call today and schedule your first consultation completely free of charge.
Full Answer
Cordis Optease IVC Filter Recall. In March 2013, FDA announced a Class 1 recall [] for 33,000 Optease IVC filters for a labeling correction to minimize the risk of implanting the device backwards.Affected filters were distributed in the U.S. from May 5, 2010 to April 2, 2013.
Need an IVC Filter Lawyer in Texas? Collen A. Clark is a true advocate for his clients and is passionate about helping Texans. If you or a loved one has an IVC filter implant, even if you were not injured by side effects, you should contact our lawyers immediately. You may be entitled to compensation by filing a lawsuit.
between $100,000 and $500,000Based on the IVC filter verdicts and the history of mass tort litigation, settlements may average between $100,000 and $500,000 for significant injury cases but there will certainly be cases that settle higher and lower than that payout range.
Retrievable IVC filter should be removed according to manufacturer and clinical guidelines and assessment. These devices are placed and removed by an IR physician using precision image guidance. The removal procedure is done, usually on an outpatient basis, under light sedation. The process is similar to insertion.
Lawsuits filed in federal court allege that defects in the design of IVC filters manufactured by Bard and Cook make them more likely fracture, migrate, tilt or perforate the inferior vena cava. In some cases, when the devices break, pieces can travel through the body, damaging the heart, lungs and other organs.
According to the FDA and Radiological Society of North America IVC filters should be removed once the danger of a life-threatening clot is over. Although the procedure to remove the filter is also minimally-invasive, removing the device may be challenging especially after prolonged dwell times.
Procedure times can be anywhere from 30 minutes to 4 hours. Typical interventional procedures are anywhere from 1 to 4 hours. You will be on bed rest for a minimum of 2 hours, after the procedure. Please have someone available to drive you home after the procedure as you will not be able to drive.
When should an IVC filter be removed? It is recommended that a removable filter be removed when the risk of a blood clot traveling to the lungs has passed, or if a patient can take blood thinners.
Most manufacturers make their inferior vena cava (IVC) filters of non-ferromagnetic materials, meaning IVC filters are typically MRI safe.Dec 27, 2019
There are three FDA Class II recalls of IVC filters – the Bard Denali, the Greenfield, and the Cordis OPTEASE filters. There is a Class III FDA recall of the Gunther Tulip filter.Dec 27, 2019
New Appellate Ruling in Cook MDL Class Action On December 16, 2022, the Seventh Circuit ruled in favor of two Cook IVC filter plaintiffs, reversing the MDL judge who had dismissed their claim citing the statute of limitations.Feb 1, 2022
Until recently, IVC filters were available only as permanently implanted devices. Newer filters, called optionally retrievable filters, may be left in place permanently or have the option to potentially be removed from the blood vessel later.
But blood clot filters can also be dangerous. An IVC filter left in too long can perforate the vein or detach from the vein and migrate elsewhere, causing unintended blockages or damage.Dec 15, 2015
About the Procedure IVC Filter placement and removal is a minimally invasive surgery. The implantation of the IVC filter involves a local anesthetic and numbing medication injected in your skin in the area that the IVC filter will be inserted, preventing discomfort during the surgery.
The Optease Retrievable Vena Cava Filter is a small, cage-like device that is implanted in the inferior vena cava just below the kidneys. The filter is designed to capture an embolism, a blood clot that has broken loose from the lower body on its way to the heart and lungs. Optease is made by Cordis Corporation, and was cleared for sale on the U.S.
On May 6, 2014, FDA updated a 2010 Safety Communication after receiving more than 1,000 adverse event reports associated with IVC filters. These included:
In March 2013, FDA announced a Class 1 recall for 33,000 Optease IVC filters for a labeling correction to minimize the risk of implanting the device backwards. Affected filters were distributed in the U.S. from May 5, 2010 to April 2, 2013.
The Medical Device Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in IVC filter lawsuits. We are handling individual litigation nationwide and currently investigating potential settlements in all 50 states.
Cordis Corporation manufactures the OptEase inferior vena cava (IVC) filter. It is a temporary implant designed to be removed when it is no longer necessary. The longer it remains implanted, the higher the risk of complications.
In March 2013, about 33,000 OptEase filters were recalled because a labeling error might cause it to be implanted backward. If this occurred, there would be nothing to stop the filter from migrating in the bloodstream to a patient’s heart. Click here to read more.
Cordis Corporation manufactures the OptEase retrievable vena cava filter. It is implanted in a patient’s inferior vena cava (IVC) to prevent blood clots in the lower half of the body from traveling to the lungs and causing a pulmonary embolism.
In March 2013, Cordis recalled about 33,000 OptEase Retrievable Vena Cava Filters due a labeling error involving an arrow pointing the wrong way on a storage tube.
Cordis is participating in the PRESERVE clinical trial, a 5-year safety study involving seven types of retrievable vena cava filters. The study began in early 2015 and will enroll about 2,100 patients, including at least 300 who are implanted with the TrapEase or OptEase vena cava filter.
The FDA has issued several warnings about the dangers of leaving retrievable vena cava filters implanted for long periods of time, after the patient is no longer at risk of a pulmonary embolism.
The longer a retrievable filter remains implanted, the higher the risk of complications such as:
Hundreds of people who were injured by vena cava filters have already filed lawsuits against manufacturers like C.R. Bard and Cook Medical. These lawsuits are not part of a class action — instead, they are individual lawsuits that have centralized at the federal level in Arizona and Indiana ( MDL No. 2570 ).
Free Confidential Lawsuit Evaluation: If you or a loved one has an IVC Filter, our lawyers would like to speak with you immediately. We are evaluating every case regardless of whether you experienced side effects or not. You may be entitled to compensation by filing a lawsuit.